Skip to main content
. 2006 Dec 19;96(1):157–161. doi: 10.1038/sj.bjc.6603506

Table 1. Basic demographic data.

  Diagnostic processesa N=102 744
Year
 2001 7968 7.8%
 2002 20 559 20.0%
 2003 23 894 23.3%
 2004 24 023 23.4%
 2005 26 300 25.6%
   
Age
 Mean and s.d. 54.9 (11.0)
 Median and range 54 (18–95)
 <50 years 36 282 35.3%
 50–69 years 57 057 55.5%
 >=70 years 9405 9.2%
   
Body mass index 25.7 (4.9)
Nulliparous 19.4%
History of breast cancer 6.3%
Family history of breast cancer 15.5%
Age at menarche (in years) 13.6 (1.6)
Menopause 50.2%
Age at menopause (in years) 48.6 (6.3)
   
HRTb (>1year)
 Of all patients 38.6%
 Of menopausal patients 49.9%
   
Actual clinical findingsc 14 792 14.4%
a

59 514 patients.

b

HRT=Hormonal replacement therapy.

c

Any actual sign of mastodynia, induration, nipple discharge, lump, lymph node enlargement or any benign, unclear and malignant finding.